Depomed, Endo Drop Patent Suit Over Painkiller Opana ER
Pharmaceutical companies Endo and Depomed told a New Jersey federal court on Wednesday that they seek to dismiss all claims and counterclaims in their dormant fight over whether painkiller Opana ER...To view the full article, register now.
Already a subscriber? Click here to view full article